INTRODUCTION
Bone grafts have been widely used. The supply of autografts is limited, and such grafts are liable to complications during harvesting. 1, 2 Allografts carry the risk of transmitting infection, and compared to bone substitutes their incorporation into the recipients tissues and mechanical properties are less favourable. They also require a bone bank for procurement and processing. Bone substitutes are made of calcium-containing salts and bioceramics and have no such limitations and risks. Early products had unmatched biomechanical properties and erratic bio-absorbability, 3, 4 leading to inferior outcomes. Nonetheless, bone substitutes have improved in various ways and yield comparable outcomes to autografts. 5, 6 Hong Kong has 2 major musculoskeletal tissue banks that procure tissues from living and deceased donors and provide allogenic bones, cartilages, ligaments, and tendons for clinical use. Banks that procure femoral heads only require less complicated logistics, manpower, and infrastructure; a few regional hospitals are capable of running such banks to procure femoral heads from living donors who undergo hip arthroplasty. 7 We therefore compared the cost of femoral head banking versus that of bone substitutes.
MATERIALS AND METHODS
Records of femoral head banking practice from a Hong Kong musculoskeletal tissue bank between 1998 and 2008 were reviewed. All data were crosschecked with hardcopies of the laboratory and the Clinical Management System-a computerised medical record system of patients attending the public health care sector run by the Hospital Authority. All episodes of hospitalisation, investigations, and clinic appointments were computerised since 1997. 8 The bone bank observed practices based on guidelines of the American Association of Tissue Banks, the European Association of Tissue Banks, the Asia Pacific Association of Surgical Tissue Banking, and the Hong Kong Red Cross Blood Transfusion Service. It was run by a dedicated technician and supervised by a specialist in orthopaedic surgery.
Donor selection criteria followed the safety of tissue transplantation practice. All potential donors had to have no evidence of acquired immunodeficiency syndrome, active systemic infection, active infection in the surgical field, malignancy, active hepatitis, connective tissue disease, intravenous drug abuse, avascular necrosis of the procured bone, and long-term steroid use. Informed consent for bone donation was obtained together with the consent for hemiarthroplasty or total hip arthroplasty.
Preoperative serological tests were performed for anti-human immunodeficiency virus type I and type II antibodies, hepatitis B surface antigen and antibody, and anti-hepatitis C virus antibodies. A venereal disease research laboratory (VDRL) test was also performed. The results of these tests were usually not available by the time of surgery.
During harvesting of the femoral head, bone tissues were taken from the fracture site for aerobic, anaerobic, and mycobacterial cultures, as well as histological study. Without further processing (irrigation or immersion into antibiotic solution), the femoral head was put in a stainless steel jar and stored in the 'quarantine' compartment of a freezer at -80°C. So long as all screening tests returned nil abnormal, the package was transferred to the 'ready' compartment. Before use, the femoral head was swabbed for both aerobic and anaerobic bacterial culture, and then immersed into aqueous hibitane for 30 minutes while thawing. A no-return policy was adopted.
Costs for all screening tests were inferred based on the Hospital Authority's charge list, whereas manpower costs were derived from payroll data. Based on estimates of the relevant technician, banking for femoral heads accounted for 30% of that individual's workload and took up 70% of the freezer capacity. Corresponding electricity costs for the freezer were estimated according to its power consumption and per kilowatt-hour charges. 9 Summation of these costs was taken as the direct cost of running the femoral head bank.
The wet gross weight and dry weight of each femoral head was estimated, based on a study on 20 discarded femoral heads from elderly patients undergoing hip hemiarthroplasty for displaced femoral neck fractures. None of the patients had hip pathology such as arthritis or tumour. The dry weight was the weight of the collected cancellous bone after washing and drying. (Table 3) , each femoral head cost US$888. The final figure became US$978 when logistic errors and wastage were also added.
RESULTS
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The prevalence of hepatitis B antigenaemia and positive VDRL tests was 6.7% and 3.0%, respectively (Table 4) , and hepatitis C and human immunodeficiency virus antibody tests were positive in 0.4% and 0.2%, respectively. 1.1%, 0.2%, and 0.6% of the femoral heads were found to contain aerobic microbes, mycobacteria, and malignant tissue, respectively.
The mean wet gross weight of a femoral head was 34.3 (range, 24.3-55.8; SD, 6.4) g. The mean dry weight of the collected cancellous bone was 11.4 g. Therefore, each gram of cancellous bone suitable for transplant cost US$78 to 86, depending on whether logistic errors and wastage were considered.
Calcium phosphate ceramic (Triosite; Zimmer, Swindon, UK) costs US$9 per gram. The injectable form of bone substitute (JectOs; Kasios, Launaguet, France) costs much more (US$26 per gram).
DISCUSSION
The demand for bone grafting is ever growing. As the population ages, more percentage of elderly patients with osteoporotic bones sustain fractures, which often leads to bone defects following reduction. Typical examples of procedures to deal with these problems include kyphoplasty of collapsed vertebrae and reduction of Colles' fracture. 10 Furthermore, revision joint replacement surgeries for osteolysis, implant loosening, and bone defects also demand means of filling voids and bone stock replenishment.
Autografts result in donor-site morbidity.
1,2
Allografts are traditionally provided by full-scale tissue banks. Such banks require complex logistic and infrastructure that may not be feasible for most regional hospitals. Banks dedicated to storing femoral heads only may be more affordable.
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In the past, allografts were regarded as superior to bone substitutes because of their osteo-inductive nature. Incorporation of bone morphogenic protein into bone substitutes 12 leads to outcomes comparable to those of autografts, 5, 6 in addition to conferring a better safety profile, uniformity in mechanical properties, and physical dimensions. Their storage is less complicated as they do not require coldchain logistics. Furthermore, introduction of the injectable form of bone substitutes (e.g. JectOs; Kasios, Launaguet, France) enables percutaneous application.
Without taking into account the costs of screening tests and manpower, bone banks are considered an economical solution. 13 However, these 2 factors contribute most to relevant expenditure. Tactics with respect to screening tests should be adopted to lower
Reasons
No. Another tactic, though uncommonly practised, is to pool the serum from 2 donors for testing. The cost of screening tests could then be lowered at the expense of more discarded femoral heads. This tactic is not suitable for screening for hepatitis B, as the carrier rate is up to 8% in Hong Kong.
14 Nonetheless, for hepatitis C and human immunodeficiency virus tests, the carrier rates are 0.5% 14 and 0.1%, 15 respectively. Therefore, the increased discard rate owing to the practice of pooled serological tests may be negligible. The safety profile of this tactic remains to be confirmed, as pooled serum dilutes the antibody titre.
In our study, anaerobes were never cultured from any specimen. Anaerobes rarely cause septic arthritis, except in neonates and immunosuppressed patients. Nonetheless, omitting this test is not a safe option. The contamination rate with anaerobes was 0.7% in a local bone bank. 7 In Singapore, anaerobes contributed to up to 17% of all instances of bacterial contamination. 16 The 19.5% discard rate in our bone bank samples was comparable to the 20% reported from Singapore. 16 Improving logistics can bring down the discard rate to 11.5%. This may lower the screening costs by up to US$4.7 per gram. Even when all these measures are practised, allogenic bone grafts still appear much more expensive than bone substitutes. The screening costs would escalate further if tests for human Tlymphotropic virus and cytomegalovirus were also to be performed.
Our study has limitations owing to its retrospective nature. The amount of bone harvested was estimated based on another study. The direct costs (screening test, payroll, and electricity) may not be applicable to other localities. The results cannot be projected to bone harvested from deceased donors, as the procurement process differs and the amount of bone collected is much more than from a single femoral head, which may well lower the mean cost per gram considerably. Our study also neglected indirect costs such as initial investment and subsequent depreciation of the equipment, lengthening in operating times to process the femoral heads, and the possible risk of graft contamination 7, 17 and infection. The bone quality of these femoral heads is usually inferior, because most donors are elderly and have osteoporotic bone. Compared with bone substitutes, femoral head banking in Hong Kong was less economical. Nonetheless, our study cannot infer cost effectiveness because treatment outcomes were not compared. Bone substitutes cannot replace freshfrozen cancellous allografts in all clinical applications (e.g. impaction grafting in the revision of total hip replacement). Unless allografts yield superior outcomes, harvesting femoral heads for general usage (such as filling bone voids of fresh fractures) is less justified from a financial perspective, especially in banks dedicated to procuring bone from femoral heads only.
